Alnylam Pharmaceuticals
Pioneer in RNA interference (RNAi) therapeutics, developing and commercializing siRNA-based medicines for genetic diseases, cardio-metabolic diseases, and infectious diseases.
Website
https://www.alnylam.comLocation
Cambridge, Massachusetts, USA
Founded
2002
Investors
2
Categories
biotech, rna-therapeutics, rnai, genetic-medicine, pharma
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| ARCH Venture Partners | Chicago, USA | biotech-focused | seedseries-a+3 | 6 |
| Polaris Partners | US | biotech-focused | - | 33 |